- $40.46bn
- $41.28bn
- $4.34bn
Brief: Illumina Q2 Adjusted EPS USD 1.31 Vs. IBES Estimate USD 1.23
Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift (updated)
Danaher's revenue outlook cut, biotech miss overshadow profit forecast raise
Danaher falls after cutting annual revenue growth forecast
Roche takes aim at Illumina's dominance with new gene sequencing machine (updated)
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
Illumina rises after J.P. Morgan upgrades to 'overweight'
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
Apple, Boeing, Citi, Tesla, Meta executives to join Trump's China trip (updated)
Shanghai stocks hit 11-year highs in AI frenzy ahead of Trump-Xi meeting
Tech shares lead China, Hong Kong markets higher ahead of Trump-Xi meeting
China's yuan strengthens against the dollar ahead of Trump-Xi meeting
U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, Illumina
U.S. STOCKS ON THE MOVE-BuzzFeed, GameStop, Under Armour
Illumina up after CEO to join Trump's China trip
Analysis: US CEOs seek China business gains from Trump-Xi summit